Download PDF
CC BY-NC-ND 4.0 · Arch Plast Surg 2022; 49(05): 611-613
DOI: 10.1055/s-0042-1756295
Breast/Trunk: Case Report

Late Seroma in Breast Implants: A Coronavirus Disease 2019 Phenomenon?

Stephanie L.S Chan 
1   Department of Plastic, Reconstructive and Aesthetic Surgery, KK Women's and Children's Hospital, Singapore
,
James Wan Loong Mok 
1   Department of Plastic, Reconstructive and Aesthetic Surgery, KK Women's and Children's Hospital, Singapore
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has been challenging in all aspects of the medical field with new clinical presentations constantly arising. Plastic surgeons are not immune to this and need to be aware of their implications. There has been a recent report of late periprosthetic seroma (breast implant) as a clinical manifestation of COVID-19 infection. To our knowledge, this phenomenon has not been further reported. We present a 53-year-old immunocompromised lady who developed late seroma after COVID-19 infection. She eventually required explantation of the implant and is awaiting autologous reconstruction. It is likely that we will increasingly continue to see this phenomenon of implant complications as a result of COVID-19 infection and should be watchful, especially regarding potential immunocompromised patients.

Keywords

late seroma - seroma - breast implant - coronavirus - coronavirus disease 2019

Authors' Contributions

S.L.S.C. drafted the paper, preformed data collection and literature review. W.L.J.M. conceptualised and finalised the paper.


Patient Consent

Informed consent for publication was obtained from the patient.




Publication History

Received: 08 December 2021

Accepted: 07 July 2022

Article published online:
23 September 2022

© 2022. The Korean Society of Plastic and Reconstructive Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • Reference

  • 1 Núñez PM, González MP, Cordero ÁJ.. Late seroma of the breast in association with COVID-19 infection: two case reports. Eur J Plast Surg 2021; 1–4: 1-4
    Google Scholar
  • 2 Weitgasser L, Mahrhofer M, Schoeller T. Potential immune response to breast implants after immunization with COVID-19 vaccines. Breast 2021; 59: 76-78
    CrossrefPubMedGoogle Scholar
  • 3 Kayser F, Fourneau H, Mazy OC, Mazy S. Breast implant seroma: a SARS-CoV-2 mRNA vaccine side effect. J Clin Ultrasound 2021; 49 (09) 984-986
    CrossrefPubMedGoogle Scholar
  • 4 Mahrhofer M, Weitgasser L, Schoeller T. Observations of a potential immune response to breast implants after immunization with COVID-19 vaccines. Aesthet Surg J Open Forum 2021; 3 (04) ojab035
    CrossrefPubMedGoogle Scholar
  • 5 Restifo RJ. A case report of capsular contracture immediately following COVID-19 vaccination. Aesthet Surg J Open Forum 2021; 3 (03) ojab021
    CrossrefPubMedGoogle Scholar
  • 6 Munavalli GG, Guthridge R, Knutsen-Larson S, Brodsky A, Matthew E, Landau M. COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment. Arch Dermatol Res 2022; 314 (01) 1-15
    CrossrefPubMedGoogle Scholar
  • 7 U.S. Food and Drug Administration. Vaccines and Related Biological Products Advisory Committee Meeting; FDA Briefing Document for Moderna COVID 19. Vaccine. Accessed March 22, 2021, at: https://www.fda.gov/media/144434/download
    Google Scholar